Lasting Outcomes for Imatinib in Chronic Myeloid Leukemia
Estimated overall survival 83.3 percent at 10 years for patients in imatinib treatment group
ACA’s Medicaid Expansion May Pose Challenges to Timely Care
Research shows benefit, but also more problems with patients getting appointments
Soy Linked to Prolonged Survival in Some Breast Cancer Patients
Association strongest for women with ER-negative/PR-negative tumors
Study Finds No Link Between Cytomegalovirus, Glioblastoma
Researchers find no evidence of cytomegalovirus in tumor tissue
Cancer Screening Remains Below Healthy People 2020 Targets
From 2000 to 2015, increases in CRC screening use, but not in breast, cervical cancer screening
Republicans Introduce Affordable Care Act Replacement
Initial Republican replacement for the Affordable Care Act formally introduced Monday
Cost-Effectiveness Compared for Metastatic Melanoma Treatments
First-line pembrolizumab or nivolumab followed by second-line ipilumumab most cost-effective
Blinatumomab Linked to Longer Survival in Adults With ALL
Significantly longer overall, event-free survival for relapsed, refractory B-cell precursor ALL
Neurofeedback Aids in Reducing Chemo-Related Nerve Damage
Clinically and statistically significant reductions in peripheral neuropathy seen following neurofeedback
Most Health Care Providers Can Offer Cost Estimate
Although 75 percent of provider organizations can offer estimate, only 25% of patients request one
